Blood-saving methods in reconstructive maxillo-facial surgery.

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IIR-17010554

Enrollment

Unknown

Registered

2017-02-06

Start date

2016-11-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood loss

Interventions

Control (I):Acute normovolaemic hemodilution

II:Aprotinin

III:Tranexamic acid

IV:Tranexamic acid with local sympatolysis

V:Tranexamic acid with system sympatolysis

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Length of operation min 300 min. ASA status - I-II.

Exclusion criteria

Exclusion criteria: ASA status - III-V.

Design outcomes

Primary

Measure	Time frame
Blood loss;	—

Countries

Russia

Contacts

Public ContactAndrey Zajcsev

FSBSI

rabotaz1@rambler.ru+79 037553095

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026